WA
The startup offers liquid biopsy tests for early cancer detection and a pan-cancer chemotherapy drug resistance screening, providing oncologists with precise data to inform treatment decisions. This technology enables patients to access tailored cancer treatment options, addressing the need for effective and localized cancer care in Africa.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup offers liquid biopsy tests for early cancer detection and a pan-cancer chemotherapy drug resistance screening, providing oncologists with precise data to inform treatment decisions. This technology enables patients to access tailored cancer treatment options, addressing the need for effective and localized cancer care in Africa.